IL6 and nasopharyngeal carcinoma: Notably, IL6 is generally upregulated in NPC cells and its high expression is associated with cisplatin resistance and radioresistance (Yuan et al., 2021; Zhu et al., 2021), and nevertheless, Celastrol upregulated its expression.